Sedation in the paediatric intensive care unit

Current Opinion in Anaesthesiology

Volumn 9, Issue 3, 1996, Pages 239-243

  Erb, Thomas ^a   Frei, Franz J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; ISOFLURANE; KETAMINE; OPIATE; PROPOFOL; SEDATIVE AGENT;

CENTRAL NERVOUS SYSTEM DEPRESSION; CHILD; DRUG WITHDRAWAL; HUMAN; INFANT; INTENSIVE CARE; PEDIATRICS; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION; SHORT SURVEY;

EID: 0029935910     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199606000-00011     Document Type: Short Survey

References (39)

1. Marx CM, Rosenberg Dl, Ambuel B, Hamlett KW, Blumer JL: Pediatric intensive care sedation: survey of fellowship training programs. Pediatrics 1993, 91:369-378.
2. Southall DP, Cronin BC, Hartmann H, Harrison-Sewell C, Samuels MP: Invasive procedures in children receiving intensive care. BMJ 1993, 306:1512-1513.
3. Ambuel B, Hamlett KW, Marx CM, Blumer JC: Assessing distress in pediatric intensive care environments-the COMFORT scale. J Pediatr Psychol 1992, 17:95-109.
4. Marx CM, Smith PG, Lowrie LH, Hamlett KW, Ambuel B, Yamashita TS, Blumer JL: Optimal sedation of mechanically ventilated pediatric critical care patients. Crit Care Med 1994, 22:163-170. The simultaneous independent rating conducted by trained observers applying an objective scale (the 'Comfort' scale) and intensive care physicians using global assessment in mechanically ventilated children is compared. The 'Comfort' scale measures adequate sedation more consistently.
5. Hansen-Flaschen J, Cowen J, Polomano RC: Beyond the Ramsey scale: need for a validated measure of sedating drug efficacy in the intensive care unit Crit Care Med 1994, 22:732-733.
6. Spencer EM, Willatts SM: Isoflurane for prolonged sedation in the intensive care unit: efficacy and safety. Crit Care Med 1992, 18:415-421.
7. Arnold JH, Truog RD, Molengraft RN: Tolerance to isoflurane during prolonged administration. Anesthesiology 1993, 73:985-988.
8. Kelsall AWR, Ross-Russell R, Heirick MJ: Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med 1994, 22:1032-1034.
9. Kong KL, Willatts SM: Isoflurane sedation in pediatric intensive care. Crit Care Med 1995, 23:1308-1309.
10. Hartwig S, Roth B, Theisohn M: Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit Eur J Pediatr 1991, 150:784-788.
11. Sheridan RL, McEttrick M, Bacha G, Stoddard F, Tompkins RG: Midazolam infusion in pediatric patients with burns who are undergoing mechanical ventilation. J Burn Care Rehabil 1994, 15:515-518.
12. Brooker PD, Beechey A, Lloyd-Thomas AR: Sedation of children requiring artificial ventilation using an infusion of midazolam. Br J Anaesth 1986, 58:1104-1108.
13. Bauer TM, Ritz R, Haberthür C, Ha HR, Hunkeler W, Sleight AJ, Scollo-Lavizarri G, Haefeli WE: Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995, 346:145-147. High levels of conjugated metabolites of midazolam are shown to be responsible for prolonged sedation in patients with renal failure, since the parent drug as well as the unconjugated main metabolites were well below the therapeutic range. Quick arousal occurred after administration of flumazenil.
14. Rivera R, Segnini M, Baltodano A, Penez A: Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993, 23:991-994.
15. Malinovsky JM, Populaire C, Cozian A, Lepage JY, Lejus C, Pinaud M: Premedication with midazolam in children. Effect of intranasal, rectal and oral routes on plasma midazolam concentrations. Anaesthesia 1995, 50:351-354.
16. Tobias JD, Rasmussen GE: Pain management and sedation in the pediatric intensive care unit Pediatr Clin North Am 1994, 41:1269-1292.
17. Spivey WH: Flumazenil and seizures: analysis of 43 cases. Clin Ther 1992, 14:293-305.
18. Sugarman JM, Paul RI: Flumazenil: a review. Pediatr Emerg Care 1994, 10:37-43. This article gives a representative overview of the use of flumazenil in the paediatric emergency and intensive care setting, with many useful details.
19. Tobias JD, Martin LD, Randall C, Wetzel C: Ketamine by continuous infusion for sedation in the pediatric intensive care unit Crit Care Med 1990, 18:819-821.
20. Hartvig P, Larsson E, Joachimsson PO: Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine. J Cardiothorac Vasc Anesth 1993, 7:148-153.
21. Rock MJ, Reyes de Ia Rocha S, L'Hommedieu CS, Truemper E: Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 1986, 14:514-516.
22. Olkkola KT, Hamunen K, Maunuksela E: Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children. Clin Pharmacokinet 1995, 28:385-404. An excellent, up-to-date review of the topic. It shows clearly that pharmacokinetic as well as pharmacodynamic characteristics of the various opioids differ markedly according to the patient's age.
23. Chay PC, Duffy BJ, Walker JS: Pharmacokinetic-pharmacodynamic relationship of morphine in neonates. Clin Pharmacol Ther 1992, 51:334-342.
24. Lynn AM, Nespeca MK, Opheim KE, Slattery JT: Respiratory effects of intravenous morphine infusions in neonates, infants and children after cardiac surgery. Anesth Analg 1993, 77:695-701.
25. Ovadia D, Klein J, Bohn D, Koren G: Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994, 22:1099-1101
26. Wessel DL: Hemodynamic responses to perioperative pain and stress in infants. Crit Care Med 1993, 21:S361-S362.
27. Gauntlett IS, Fisher DM, Hertzka RE, Kuhls E, Spellman MJ, Rudolph C: Pharmacokinetics of fentanyl in neonatal humans and lambs: effect of age. Anesthesiology 1988, 69:683-687.
28. Katz R, Kelly HW: Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med 1993, 21:995-1000.
29. Irazuzta J, Pascucci R, Perlman N, Wessel D: Effects of fentanyl administration on respiratory system compliance in infants. Crit Care Med 1993, 21:1001-1004.
30. Sperry RJ, Bailey PL, Reichman MV, Peterson JC, Peterson PB, Pace NL: Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology 1992, 77:416-420.
31. Tobias JD: Increased intracranial pressure after fentanyl administration in a child with closed head trauma. Pediatr Emerg Care 1994, 10:89-90.
32. Committee on Drugs and Committee on Environmental Health: Use of chloral hydrate for sedation in children. Pediatrics 1993, 92:471-472.
33. Tobias JD, Deshpande K, Pietsch JB, Wheeler TJ, Gregory DF: Pentobarbital sedation for patients in the pediatric intensive care unit South Med J 1995, 88:290-294.
34. Parke TJ, Stevens JE, Rice ASC, Geenaway CL, Bray RJ, Smith PJ, Waldmann CS, Verghese C: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992, 305:613-616.
35. Strickland RA, Murray MJ: Fetal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med 1995, 23:405-409.
36. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, Zeitz PS, Jarvis WR: Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995, 333:147-154 In this large study, performed at several institutions, unusual outbreaks of surgical infection complications were analyzed. By using case-control or cohort studies, the authors show convincingly that the perioperative administration of propofol is significantly associated with postoperative complications caused by specific aetiologic bacterial strains.
37. Van Engelen BGM, Gimbrere JS, Booy LH: Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother 1993, 27:579-581.
38. Katz R, Kelly HW, Hsi A: Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 1994, 22:763-767. In small children (1 week-22 months), predictors of withdrawal symptoms after continuous fentanyl infusions were sought. It can be shown that duration and total dose are significantly correlated with the incidence of withdrawal reaction. A total dose of greater than 2.5 mg/kg or a duration of infusion of greater than 9 days was 100% predictive of withdrawal symptoms.
39. Anand KJS, Arnold JH: Opioid tolerance and dependence in infants and children. Crit Care Med 1994, 22:334-342.